(Received 8 December 2002; accepted 7 December 2002)
Published Online: May
| ||Format||Pages||Price|| |
|PDF Version||2||$25||  ADD TO CART|
We describe the application of histochemical demonstration of chromium in a case of fatal ingestion of potassium dichromate in a suicide attempt. Using 2-(8-quinolylazo)-4,5-di-p-tolylimidazole (QTI), we could demonstrate chromium in the erythrocyte of the victim, in situ. This finding provides a means of proving the hexavalent chromium ingestion.
Stock #: JFS2002349